Icagen

Icagen

Biotechnology, 1035 Swabia Court, Durham, North Carolina, 27703, United States, 51-200 Employees

icagen.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 91********

Who is ICAGEN

Icagen partners with global pharmaceutical and biotech companies to generate high-quality, advanced leads. As a focused, Target-to-Lead (T2L) company, Icagen works with collaborators in m...

Read More

map
  • 1035 Swabia Court, Durham, North Carolina, 27703, United States Headquarters: 1035 Swabia Court, Durham, North Carolina, 27703, United States
  • 1992 Date Founded: 1992
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2835 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ICAGEN

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Icagen

Answer: Icagen's headquarters are located at 1035 Swabia Court, Durham, North Carolina, 27703, United States

Answer: Icagen's phone number is 91********

Answer: Icagen's official website is https://icagen.com

Answer: Icagen's revenue is $25 Million to $50 Million

Answer: Icagen's SIC: 2835

Answer: Icagen's NAICS: 325412

Answer: Icagen has 51-200 employees

Answer: Icagen is in Biotechnology

Answer: Icagen contact info: Phone number: 91******** Website: https://icagen.com

Answer: Icagen partners with global pharmaceutical and biotech companies to generate high-quality, advanced leads. As a focused, Target-to-Lead (T2L) company, Icagen works with collaborators in multi-year, integrated drug discovery programs as well as piecemeal projects to fill-in the gaps of R&D efforts. Born from a biotech background and matured by pharma companies, Icagen brings to partners a North American team with over 20 years of experience in early discovery. The process of drug discovery starts with druggable targets. Icagen scientists have vast experience in target-based drug discovery, including ion channels, kinases, GPCR’s and transporters. The Icagen team works with collaborators to determine target feasibility using state-of-the-art computational chemistry methods. Once a target is selected the team combines virtual screening, ultra-high throughput screening (uHTS), biology and medicinal chemistry to generate viable leads in an iterative process.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access